CD81

CD81 Product List

  • Product Category

    Protein (2)

  • Product Status

    Launched (2)

  • Species

    Human (2)

  • Tag

    His Tag & Avi Tag & Flag Tag (1)- (1)

  • Conjugate

    Biotin-labeled (1)Unconjugated (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
CD1-H52P5
Human
HEK293
Human CD81 Full Length Protein (VLP)
CD1-H85D8
Human
InsectCells
Biotinylated Human CD81 Protein, His,Avitag™&Flag Tag (Detergent)
Total: 2
  • 1

CD81 Background

The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is a cell surface glycoprotein that is known to complex with integrins. This protein appears to promote muscle cell fusion and support myotube maintenance. Also it may be involved in signal transduction. This gene is localized in the tumor-suppressor gene region and thus it is a candidate gene for malignancies. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
IBC-0966IBC-0966Phase 2 ClinicalSunHo (China) BioPharmaceutical Co LtdNeoplasms
Details
BI-765063OSE-172; BI-765063Phase 1 ClinicalOse ImmunotherapeuticsSolid tumours; Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung
Details
AnzurstobartBMS-986351; CC-95251Phase 1 ClinicalCelgene CorpMyelodysplastic Syndromes; Leukemia, Myeloid, Acute
Details
ADU-1805ADU-1805Phase 1 ClinicalAduro Biotech IncSolid tumours; Neoplasms; Neoplasm Metastasis
Details
LM-101LM-101Phase 1 ClinicalLaNova Medicines LtdLeukemia; Solid tumours; Hematologic Neoplasms; Neoplasms
Details
Q-1801Q-1801; Q 1801Phase 1 ClinicalQiyu Biotechnology (Shanghai) Co LtdSolid tumours
Details
Recombinant humanized IgG4 anti-SIRPα antibody(Daiichi Sankyo)DS-1103aPhase 1 ClinicalDaiichi Sankyo Co LtdSolid tumours; Breast Neoplasms
Details
ELA-026ELA-026Phase 1 ClinicalElectra Therapeutics IncLymphohistiocytosis, Hemophagocytic
Details
BYON-4228BYON-4228Phase 1 ClinicalByondis BvSolid tumours; Lymphoma
Details
BSI-082BSI-082Phase 1 ClinicalBoaoxin Biotechnology(Nanjing) Co LtdHematologic Neoplasms; Solid tumours
Details
BR-105BR-105; BR105Phase 1 ClinicalBioRay Pharmaceutical Co LtdNeoplasms; Lymphoma, Large B-Cell, Diffuse
Details
[89Zr]Zr- BI-765063(Boehringer Ingelheim)Phase 1 ClinicalBoehringer Ingelheim CorpSquamous Cell Carcinoma of Head and Neck; Carcinoma, Non-Small-Cell Lung; Melanoma
Details
TQB-2928TQB-2928Phase 1 ClinicalHematologic Neoplasms; Solid tumours; Myelodysplastic Syndromes; Neoplasms; Leukemia, Myeloid, Acute
Details
BI-765080Phase 1 ClinicalC.H. Boehringer Sohn Ag & Co. Kg
Details
ES-004ES-004; ES 004-N4; ES 004-B4Phase 1 ClinicalSolid tumours; Neoplasms
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
Relugolix/Estradiol/Norethindrone AcetateE2/NETAApprovedMyovant SciencesMYFEMBREE, RYEQOUnited StatesMenorrhagia; LeiomyomaMyovant Sciences2021-05-26Pain; Endometriosis; Leiomyoma; Menorrhagia; Uterine Neoplasms
Details
Elagolix/estradiol/norethindrone acetateApprovedAbbvie IncOriahnnUnited StatesMenorrhagiaAbbvie Inc2020-05-29Menorrhagia
Details
  • Product List
  • Marketed Drug Information
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland